We enhance care, provide support and strive to eliminate Alzheimer's disease through the advancement of research in our state-of-the-art laboratories.

News

Congratulations to Ritika Rohatgi and Dr. Li Fan on the Successful Completion of the 2026 Appel Summer Scholar Program

The Helen & Robert Appel Institute for Alzheimer's Disease Research is proud to congratulate Ritika Rohatgi and Dr. Li Fan on the successful completion of the 2026 Appel Summer Scholar Program....

Inflammation May Drive Dravet Syndrome, Offering a Potential New Treatment Target

Brain activity traces recorded from different brain regions show frequent seizure-like activity in Dravet mouse models (left), while Dravet moouse models with genetically reduced cGAS (right) show...

Research Shifts Toward Shared Mechanisms in Neurodegenerative Diseases

Pictured left to right: Dean Robert A. Harrington, Dr. Edward Lee, Dr. Sreeganga Chandra, Helen Appel, Dr. Li Gan and Dr. Anna Orr. Credit: Reece Taylor WilliamsAlzheimer’s disease may not be a...

Events

Progress in Neuroscience Seminar (PINS)

November 5, 2026 - 4:00pm
Joe Lewcock, PhD Chief Scientific Officer Denali Therapeutics Talk Title: "Leveraging the Transport Vehicle Platform for the Development of Next-Generation CNS Therapeutics."

Emerging Leaders in Neuroscience Seminar

November 6, 2026 - 12:00pm
"Multiscale Architecture of Memory Computation in the Hippocampus" Eunji Kong, PhD, Postdoctoral Research Scientist, Zuckerman Institute, Columbia University

Work in Progress Seminar

November 20, 2026 - 12:00pm
"Modeling Alzheimer’s disease in human brain chimeras: Toward uniting the BAPtists and TAUists" Wenhui Qu, PhD, Postdoctoral Associate in Neuroscience, (Gan Lab) Appel Alzheimer's Disease Research...

Appel Alzheimer's Disease Research Institute | Click Here